1010 days ago
The fed stimulus packages have helped push up nominal retail sales to new heights. Currently, we are 15% higher than trend, which translates to being five years ahead of the trend.
1010 days ago
The tech redemption seems to continue, with outflows that had not been seen since January 2019.
1010 days ago
Demand might not catch up in time to the surplus supply of beer companies are set to produce. As GDP bounces back and income starts growing again, expect per capita consumption to grow 3% per year in the next three years. This should see demand total 15.9B liters, still about 0.5B short than the potential combined output of AmBev, Petropolis and Heineken, if they fully ramp-up capacity in four years.
1010 days ago
Ark Invest is a top holder of such stocks in the genomics space, stocks that surged upon the news that Intellia and Regeneron Pharmaceuticals produced the first study of a Crispr treatment to alter genes inside the body. Intellia led the gains, soaring 50% to close at a record on Monday, while Crispr climbed 6.4%. Beam jumped 16%. Editas gained as much as 20% before paring to a 5% gain.
1010 days ago
With stocks on track for one of their best first halves in history, the debate over elevated valuations is coming back to the forefront. The S&P 500 is trading above the average of the past decade, and this quarter potentially marking the peak of a profit recovery from the depths of the pandemic. Meantime, demand for protection against losses in coming months has risen in the options market.
